Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Targeting Oxidative Stress in Chronic Beryllium Disease
Brief Summary: The purpose of this study is to understand if a drug called mesalamine helps to control inflammation associated with chronic beryllium disease (CBD). We hypothesize that in CBD subjects treated with prednisone, mesalamine treatment will enhance the immunosuppressive effects of prednisone, and thus reduce the immune response to beryllium.